Hematopoietic Growth Factors Secreted by Seven Human Pleural Mesothelioma Cell Lines: Interleukin-6 Production as a Common Feature
The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
Seven mesothelioma cell lines, established from patients with pleural mesothelioma, exhibited substantial heterogeneity regarding in vitro morphology and growth characteristics. Media conditioned by these cell lines and by MeT5A normal mesothelial cells were examined for (i) colony formation on human bone-marrow cells, (ii) hematopoietic growth-factor content and (iii) mitogenic activity on mesothelioma cells. Colony-stimulating activity was produced only by the ZL34 cell line. Analysis of conditioned media by ELISA revealed that all mesothelioma cell lines constitutively produced IL-6, while the MeT5A normal mesothelial cells did not; in addition, GM-CSF and G-CSF were detected in the supernatant of the ZL34 cell line. Using a 3H-thymidine incorporation assay, we showed that all mesothelioma cell lines produced mitogenic activity in the culture supernatant, in contrast to the MeT5A normal mesothelial cells. The mitogenic effect of the hematopoietic growth factors detected in mesothelioma culture supernatants was tested on mesothelioma cells and on MeT5A normal mesothelial cells: IL-6, GM-CSF and G-CSF did not stimulate any DNA synthesis. Our results suggest that these hematopoietic growth factors do not act as autocrine growth factors. A common feature of this panel of mesothelioma cell lines is the production of IL-6; although the biological significance of the aberrant production of cytokines by mesotheliomas remains unclear, IL-6 might be involved in paraneoplastic syndromes such as thrombocytosis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Mesothelioma cells produce IL-6 [45,46]”
From Chronic Inflammation, Oxidative Stress and Metabolic Plasticity: Three Players Driving the Pro-Tumorigenic Microenvironment in Malignant Mesothelioma (2023) · cites this paper as [46]
In the citing paper
“Mesothelioma cells produce IL-6 [45,46], and an elevation of the circulating level of IL-6 has been already described in mesothelioma patients, with this increase being associated with a negative clinical condition. High levels of IL-6 have been also revealed in patients’ pleural fluids [47].”
From Chronic Inflammation, Oxidative Stress and Metabolic Plasticity: Three Players Driving the Pro-Tumorigenic Microenvironment in Malignant Mesothelioma (2023) · cites this paper as [46]
Citations
Cites
Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas
Kawano, M., Hirano, T., Matsuda, T., Taga, T., Horii, Y., Iwato, K., Asaoku, H., Tang, B., Tanabe, O., Tanaka, H., et al. (1988) · Nature · doi:10.1038/332083a0 · Cited by 1,633
Interleukin-6 is a potent thrombopoietic factor in vivo in mice
Ishibashi, T., Kimura, H., Shikama, Y., Uchida, T., Kariyone, S., Hirano, T., Kishimoto, T., Takatsuki, F., & Akiyama, Y. (1989) · Blood · doi:10.1182/blood.v74.4.1241.1241 · Cited by 432
Interleukin‐6 (IL‐6) functions as an in vitro autocrine growth factor in renal cell carcinomas
Miki, S., Iwano, M., Miki, Y., Yamamoto, M., Tang, B., Yokokawa, K., Sonoda, T., Hirano, T., & Kishimoto, T. (1989) · FEBS Letters · doi:10.1016/0014-5793(89)80805-1 · Cited by 411
Diffuse Malignant Mesothelioma: Prospective Evaluation of 69 Patients
CHAHINIAN, A. P., PAJAK, T. F., HOLLAND, J. F., NORTON, L., AMBINDER, R. M., & MANDEL, E. M. (1982) · Annals of Internal Medicine · doi:10.7326/0003-4819-96-6-746 · Cited by 354
The Pathogenesis of Asbestos-Associated Diseases
Craighead, J. E., & Mossman, B. T. (1982) · New England Journal of Medicine · doi:10.1056/nejm198206173062403 · Cited by 333
Berdel, W., Danhauser-Riedl, S., Steinhauser, G., & Winton, E. (1989) · Blood · doi:10.1182/blood.v73.1.80.80 · Cited by 289
In vivo effects of recombinant human interleukin-6 in primates: stimulated production of platelets
Asano, S., Okano, A., Ozawa, K., Nakahata, T., Ishibashi, T., Koike, K., Kimura, H., Tanioka, Y., Shibuya, A., & Hirano, T. (1990) · Blood · doi:10.1182/blood.v75.8.1602.1602 · Cited by 279
(1987) · Lung Cancer · doi:10.1016/s0169-5002(87)80408-7 · Cited by 263
Frei, K., Leist, T. P., Meager, A., Gallo, P., Leppert, D., Zinkernagel, R. M., & Fontana, A. (1988) · The Journal of experimental medicine · doi:10.1084/jem.168.1.449 · Cited by 245
Dedhar, S., Gaboury, L., Galloway, P., & Eaves, C. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.23.9253 · Cited by 229
Research works printed but not linked: 1
- Lee J. D., 1991, Proceedings of the 82th annual meeting AACR. Houston, 228
Cited by
Items 101–139 of 139
Wörthmüller, J., Salicio, V., Oberson, A., Blum, W., & Schwaller, B. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20215391 · Cited by 13
“For the FAK inhibitor assay, 3 × 103 cells/well were seeded in 96-well plates (TPP Techno Plastic Products AG, Trasadingen, Switzerland) and grown for 48 h.”
MethodInfluentialAdenosine diphosphate regulates MMP2 and MMP9 activity in malignant mesothelioma cells
Muscella, A., Cossa, L. G., Vetrugno, C., Antonaci, G., & Marsigliante, S. (2018) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13922 · Cited by 12
de Cupis, A., Semino, C., Pirani, P., Loprevite, M., Ardizzoni, A., & Favoni, R. E. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01907-1 · Cited by 12
Granulocyte Colony-Stimulating Factor-Producing Malignant Pleural Mesothelioma
Usami, N., 内山, 美., Kawaguchi, K., Yasuda, A., Ito, S., & Yokoi, K. (2007) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e318031b61e · Cited by 12
Inhibition of ZL55 cell proliferation by ADP via PKC‐dependent signalling pathway
Muscella, A., Cossa, L. G., Vetrugno, C., Antonaci, G., & Marsigliante, S. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.26128 · Cited by 11
Wörthmüller, J., Oberson, A., Salicio, V., Blum, W., & Schwaller, B. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19124015 · Cited by 11
“The suspension was sonicated and centrifuged at 12,000× g for 30 min at 4 ◦C. Protein concentration was determined using the Bradford Assay (Bio-Rad Laboratories AG, Cressier, Switzerland).”
MethodInfluentialExpression of hyaluronan synthases and hyaluronan in malignant mesothelioma cells.
Liu, Z., Dobra, K., Hauzenberger, D., & Klominek, J. (2004) · PubMed · Cited by 11
Tange, T., Hasegawa, Y., Oka, T., Sunaga, S., Higashihara, M., Matsuo, K., Miyazaki, H., Shimosaka, A., Okano, A., Todokoro, K., et al. (1995) · Pathology International · doi:10.1111/j.1440-1827.1995.tb03399.x · Cited by 11
Cytokine Signaling in Mesothelial Cells: Receptor Expression Closes the Autocrine Loop
Gerwin, B. I. (1996) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.14.6.8652178 · Cited by 10
Granulocyte colony-stimulating factor-producing primary pericardial mesothelioma
Horio, H., Nomori, H., Morinaga, S., Kikuchi, T., Tomonari, H., Kuriyama, S., & Suemasu, K. (1999) · Human Pathology · doi:10.1016/s0046-8177(99)90100-4 · Cited by 8
Lewko, W. M., Smalley, R. V., & Oldham, R. K. (1998) · Springer eBooks · doi:10.1007/978-94-009-0029-5_10 · Cited by 8
CONTEMPORARY APPROACHES IN THE INVESTIGATION AND TREATMENT OF MALIGNANT PLEURAL MESOTHELIOMA
Pass, H. I. (1994) · Chest Surgery Clinics of North America · doi:10.1016/s1052-3359(25)00654-4 · Cited by 8
Biological noise and positional effects influence cell stemness
Blum, W., Henzi, T., Schwaller, B., & Pecze, L. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra117.001643 · Cited by 7
“ZL55 was established from previously untreated patients as described before (37), whereas RN5 was established in our lab (38).”
BackgroundKaposi's sarcoma following malignant mesothelioma
Ascoli, V., Scalzo, C. C., Andreoni, M., Manente, L., Pistilli, A., & Coco, F. L. (1999) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s004280050448 · Cited by 7
Microenvironment and Immunology of the Human Pleural Malignant Mesothelioma
Digifico, E., Belgiovine, C., Mantovani, A., & Allavena, P. (2019) · Springer eBooks · doi:10.1007/978-3-030-16884-1_5 · Cited by 6
Gazdar, A. F. (1994) · Elsevier eBooks · doi:10.1016/b978-0-12-333530-2.50008-3 · Cited by 6
Absence of HHV-8 DNA sequences in malignant mesothelioma.
Ascoli, V., Nardi, F., Scalzo, C. C., Signoretti, S., Pistilli, A., & Coco, F. L. (1998) · Molecular Pathology · doi:10.1136/mp.51.2.113 · Cited by 5
Zubritsky, A. (2012) · InTech eBooks · doi:10.5772/1480 · Cited by 4
ADP sensitizes ZL55 cells to the activity of cisplatin
Muscella, A., Cossa, L. G., Vetrugno, C., Antonaci, G., & Marsigliante, S. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27224 · Cited by 3
Mesothelial and Mesothelioma Cell Lines
Kane, A. B. (2005) · Springer eBooks · doi:10.1007/0-387-28274-2_5 · Cited by 3
In vitro and in vivo laboratory models of pleural disease
Yao, X., & Kanellakis, N. I. (2020) · European Respiratory Society eBooks · doi:10.1183/2312508x.10032719 · Cited by 2
Lewko, W. M., & Oldham, R. K. (2009) · Springer eBooks · doi:10.1007/978-90-481-2289-9_8 · Cited by 2
Versnel, M. A. (2005) · Kluwer Academic Publishers eBooks · doi:10.1007/0-306-46872-7_4 · Cited by 2
Research progress of malignant peritoneal mesothelioma with paraneoplastic syndrome: A review
Liang, X., Li, X.-B., Fu, Y., Su, Y., Ma, R., Yang, R., Wu, H., & Li, Y. (2024) · Journal of Surgical Oncology · doi:10.1002/jso.27737 · Cited by 2
“Mesothelioma cell lines have been shown to produce IL ‐ 6, 23 so it is possible to think that large amounts of IL ‐ 6 are produced by mesothelioma cells in the abdominal cavity and continuously released into the systemic circulation, which could explain the elevated IL ‐ 6 level in ascites and…”
Advances in diagnosis and treatment of malignant mesothelioma
Hegmans, J. P. (2006) · RePub (Erasmus University Rotterdam) · Cited by 2
Haddadi, N. (2019) · OPUS - Open Publications of UTS Scholars (University of Technology Sydney) · Cited by 1
Lewko, W. M., & Oldham, R. K. (2003) · Springer eBooks · doi:10.1007/978-94-017-2757-0_8 · Cited by 1
The Role of Immunotherapy in the Treatment of Mesothelioma
Al‐Taei, S., Jason, F., & Tabi, Z. (2012) · InTech eBooks · doi:10.5772/31437
“AB12 also produce much more GMCSF than AC29 and AC29 is a much slower growing tumour (Triozzi et al., 2005).”
BackgroundInfluentialImmunoregulation by hepatocyte growth factor in malignant mesothelioma
Cook, N. L. M. (2008) · ORCA Online Research @Cardiff (Cardiff University)
MATRIX METALLOPROTEASES AND CELL MOTILITY IN MALIGNANT MESOTHELIOMA
Liu, Z. (2004) · Figshare
Szulkin, A. (2014) · Figshare
Biology of and Implications for the Treatment of Malignant Pleural Mesothelioma.
Pass, H. I. (1998) · Haigan · doi:10.2482/haigan.38.795
Angiogenesis, cyclooxygenase-2 and matrix metalloproteinases in malignant mesothelioma
Edwards, J. G. (2003) · Figshare
Kaçar, S., & Tomsuk, Ö. (2024) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.70190
Análisis de la expresión de PD-L1 en una serie de pacientes con mesotelioma pleural maligno
Cedres, S., & de Medicina, U. A. D. B. D. (2014) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Ruolo dell’infiltrato infiammatorio e dell’angiogenesi nel mesotelioma pleurico maligno
Alì, G. (2011) · Electronic Theses and Dissertations Repository (University of Pisa)
Greillier, L. (2014) · theses.fr (ABES) · doi:10.70675/2b497735zd19az4548zabcbz44e5f88e77f4
Rôle de l'adrénomédulline dans le Mésothéliome pleural malin et le cancer bronchopulmonaire
Tounsi, A. (2014) · theses.fr (ABES) · doi:10.70675/b9b82f0az4fa4z4e5czbea5z12e3b53ee430
Μελέτη των κυτταροκινών του πλευριτικού υγρού
Ξηρουχάκη, Ν. (2001) · doi:10.12681/eadd/15848
Metadata
- Authors
- Schmitter, D., Lauber, B., Fagg, B., & Stahel, R. A.
- Affiliations
- University Hospital Zurich (CH)
- Sandoz Group AG (Switzerland) (CH)
- Corresponding author
- Stahel, Rolf A.
- ORCID
- Stahel, Rolf A.
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 1992-05-08
- Volume
- 51
- Issue
- 2
- Pages
- 296-301
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W2008766290
- Cited by
- 133
- References
- 27
- Citations by year
- 2024: 3 · 2023: 1 · 2021: 2 · 2020: 3 · 2019: 5 · 2018: 8 · 2017: 3 · 2016: 4 · 2015: 5 · 2014: 6 · 2013: 2 · 2012: 8
- FWCI
- 7.48
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- International Journal of Cancer (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
- China Aerospace Science and Technology Corporation
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Occupational and environmental lung diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Health Sciences › Medicine › Surgery › Intraperitoneal and Appendiceal Malignancies
- Keywords
- pleural mesothelioma, hematopoietic growth factors, interleukin-6, GM-CSF, granulocyte colony-stimulating factor, conditioned medium, colony-stimulating activity, mitogenic activity, autocrine growth factor, paraneoplastic syndrome, thrombocytosis, mesothelial cells, cancer cell lines
- MeSH terms
- Humans, Mesothelioma, Pleural Neoplasms, Tumor Cells, Cultured, Tumor Stem Cell Assay, Interleukin-6, Granulocyte-Macrophage Colony-Stimulating Factor, Granulocyte Colony-Stimulating Factor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.